Welcure Drugs & Pharmaceuticals Ltd — Results, 05-08-2025: Result

The company's Board approved the financial results for the quarter ended June 30, 2025. Key changes in directorship include the appointment of Mr. Ravi Thakor as a Non-Executive Non-Independent Director, and Mr. Yogeshkumar Prajapati and Mrs. Bhumika Pradhan as Non-Executive Independent Directors. Concurrently, Mr. Suraj Chagan Solanki and Mrs. Deepika Krishnan Iyer resigned from their non-executive director positions. These leadership changes led to the reconstitution of the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees. Additionally, the corporate office will be relocated within Ahmedabad, impacting company operations.